-
ITAI Park welcomes a strong start
2024-04-19
The National Information Technology Application Innovation (ITAI) in Beijing E-Town saw a growth of over 100 percent in the number of newly registered enterprises during this first quarter, with the number of established businesses exceeding 300.
-
AI-empowered medical diagnosis, surgeries becoming accessible soon
2024-04-12
Companies in Beijing E-Town are actively embracing the "AI+" initiative to drive new productivity. Among these innovators is Union Strong (Beijing) Technology Co, a pioneer in applying AI to surgical procedures.
-
E-Town solution for Cardiac electrophysiology approved for market
2024-04-07
Beijing E-Town enterprise Synaptic Medical Technologies (Beijing) Co has obtained approval from the National Medical Products Administration (NMPA) for its AccuSafeTM transseptal puncture wire.
-
Xiaomi SU7 heats up EV segment
2024-04-07
The official launch of Xiaomi Corp's much-anticipated first electric vehicle will intensify competition in the crowded Chinese EV market and inject new vitality into the EV sedan segment, experts said on Friday.
-
Laser radar system supplier adds multi-million-yuan international order
2024-03-21
"Recently, we just secured an international order worth tens of millions of yuan, which is a very promising project for us to kickstart," said Dr. Ju Xueming, CEO of Beijing Liangdao Intelligent Automotive Technology Co (Liangdao Intelligence).
-
New quality productive forces launched in Beijing E-Town
2024-03-07
Beijing E-Town will anchor its second "trillion" investment target this year, 310 projects will be constructed with a total investment of 522.7 billion yuan ($72.62 billion), including 135 planned new projects with a total investment of 185.6 billion yuan.
-
How BDA's small gesture attracted Fortune 500 company
2023-10-17
-
GE Healthcare VP acknowledges China's outstanding market appeal
2023-10-13
China has always been one of the world's most promising large markets. Robust market demand, a comprehensive industrial chain, and rapidly growing innovation capabilities have made the Chinese market a vital driving force for the expansion of many global healthcare giants and a significant source for their profit growth.
-
Sanofi shows long-term commitment to China
2023-10-12
Paul Hudson, CEO of Sanofi, was recently interviewed regarding the company's development, opportunities and localization strategy in the Chinese market as well as new features and trends in the global pharmaceutical market.
-
AstraZeneca's 30 years in China: Building a sustainable health ecosystem
2023-10-11
During the first decade (1993-2003) following its entry into China, AstraZeneca held a strong belief in the vast market potential of the country, according to Wang Lei, the company's global executive vice-president and president of AstraZeneca China. During the subsequent decade (2003-2013), AstraZeneca's strategic focus developed towards manufacturing in China, resulting in the establishment of production facilities in Wuxi and Taizhou in Jiangsu province.
-
Address
Boda Building, No.15, Ronghua Middle Road, Beijing Economic-Technological Development Area
-
Email
investinbda@bda.gov.cn
-
TEL
+86-010-86409333(24h)
-
FAX
+86-010-67881207